SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Memecoin on Injective taken over by the community.

Nonja

$NONJA is currently trending as a prominent meme coin on the Injective ecosystem, driven by the rollout of Injective's EVM mainnet and strong community conviction. Many anticipate significant upside, viewing $NONJA as a high-leverage play on Injective's fundamental strength, with discussions highlighting its high burned liquidity and active community engagement.

Dynavax Technologies Corp. is a biopharmaceutical company, which engages in the provision of discovery, development, and commercialization of novel vaccines and immuno-oncology therapeutics. Its product includes HEPLISAV-B, which prevents infection caused by all known subtypes of hepatitis B virus in adults 18 years of age and older. The company was founded by Lawrence M. Lichtenstein, Dennis A. Carson, and Eyal Raz on August 29, 1996 and is headquartered in Emeryville, CA.

Dynavax Technologies Corp.

Dynavax Technologies is trending after Sanofi announced its acquisition for $15.50 per share, a move set to bolster Sanofi's adult immunization portfolio with Dynavax's hepatitis B vaccine and a shingles candidate. This news has sparked significant trading volume, with many long-term holders expressing disappointment over the acquisition price while also discussing the company's recent licensing deal for an oral COVID-19 vaccine program.

Jack in the Box, Inc. engages in the provision of developing, operating, and franchising a chain of quick-service and fast-casual restaurants. It operates through the Jack in the Box and Del Taco segments. The Jack in the Box segment offers a selection of distinctive products including classic burgers and other product lines such as Buttery Jack Burgers. The company was founded by Robert Oscar Peterson in 1951 and is headquartered in San Diego, CA.

Jack In The Box, Inc.

Jack In The Box is trending as it progresses with the strategic divestiture of Del Taco, a move widely discussed by the community as crucial for streamlining operations and managing its substantial debt. This turnaround effort, dubbed 'Jack on Track,' coupled with activist investor interest and high short interest, is fueling intense debate about the stock's potential for a significant rebound amidst its perceived undervaluation.

Injective is an interoperable Layer 1 blockchain designed for DeFi applications. It provides developers with on-chain financial infrastructure modules to build dApps such as decentralized exchanges, prediction markets, and lending protocols. Its decentralized cross-chain bridging infrastructure offers compatibility with most blockchains, including EVM chains like Ethereum and non-EVM chains like Solana.

Injective

Injective is gaining significant traction due to a substantial institutional fundraise to acquire and stake its tokens, alongside the recent launch of its native EVM mainnet, reinforcing its role in decentralized finance. The community is actively discussing $NONJA, a meme coin lauded for its strong community and robust fundamentals, viewed as a prime opportunity to leverage Injective's anticipated growth.

Derive is a decentralized protocol that creates programmable onchain options, perpetuals, and structured products.   Derive is deployed and operates on Derive Chain, an Ethereum rollup built using the OP stack and is the home of the Derive Protocol. It is a permission-less smart contract platform.  The Derive DAO earns trading fees from the Derive Protocol and gas fees from the Derive Chain, governed by DRV token holders. Trading fees accrue to an insurance fund to foster robustness of the protocol and rollup.  Derive has built an AI-powered trading app built for pro traders. In collaboration with Messari, Derive Pro translates market views into trades. The agent then prepares transactions for users and leverages smart contract wallets to make trades one-click, gasless and chainless. The app will support spot, perps and options trading on Derive, and will also plug in to spot AMMs on L2s like Optimism, Arbitrum and Base.

Derive

DRV is currently trending as the community actively discusses its significant collaboration with Synthetix to develop derivatives on Ethereum, signaling strong foundational growth. Traders are closely watching its 'slow and steady' performance and 'Onchain Matrix' tokenomics, anticipating further upside following recent consolidation and buyback discussions.

Avantis is the largest RWA perps DEX in DeFi, built on and backed by Base. Avantis allows users to trade crypto and real-world assets (RWAs), including FX, commodities, indices, and equities. Backed by Pantera and Coinbase, Avantis is the largest DEX on Base by volumes, and brings institutional-grade products to DeFi, letting users trade with up to 500x leverage in a transparent, permissionless environment.  Avantis is best known for launching zero-fee perpetuals (ZFP) — a first-of-its-kind primitive where traders only pay fees if they profit. They've also brought leveraged RWAs onchain. This has driven explosive growth: over $20B+ in cumulative volume and 15M+ run-rate revenues since Febrruary 2024.

Avantis

AVNT is actively trending due to its recent listing on Robinhood and strong positioning as a perp dex built on Coinbase's #Base platform. The community is sharply divided, with many anticipating significant gains and celebrating its recovery and Coinbase backing, while others express frustration over past performance and debate its legitimacy amidst competition with projects like Aster and Hype.

Vanda Pharmaceuticals, Inc. engages in the development and commercialization of therapies for high unmet medical needs. The firm intends to treat schizophrenia, jet lag disorder, atopic dermatitis, central nervous system disorders, and circadian rhythm sleep disorder. Its product portfolio includes HETLIOZ, Fanapt, Tradipitant, Trichostatin, and AQW051. The company was founded by Mihael Hristos Polymeropoulos and Argeris N. Karabelas in 2002 and is headquartered in Washington, DC.

Vanda Pharmaceuticals Inc

Vanda Pharmaceuticals is generating significant community excitement following positive clinical data for its drug Tradipitant in mitigating GLP-1 induced nausea and vomiting, sparking speculation about its role in the rapidly expanding obesity drug market. This, alongside favorable FDA developments for Hetlioz and multiple upcoming PDUFA dates for other pipeline assets, is fueling discussions around the stock's current undervaluation and potential for a significant re-rating or acquisition. Investors are closely watching these catalysts, anticipating a major move for the company.

Target Corp. engages in the operation and ownership of general merchandise stores. It offers food and general merchandise, clothing and household goods, electronics, and toys. Its brands include A New Day, All in Motion, Art Class, Auden, AVA & VIV, Boots and Barkley, Brightroom, Bullseye's Playground, Casaluna, Cat & Jack, Cloud Island, Colsie, dealworthy, Embark, Everspring, Favorite Day, Figmint, Future Collective, Gigglescape, Good & Gather, Goodfellow & Co, Hearth & Hand with Magnolia, Heyday, Hyde & EEK! Boutique, JoyLab, Kindfull, Kona Sol, Made By Design, Market Pantry, Mondo Llama, More Than Magic, Opalhouse, Open Story, Original Use, Pillowfort, Project 62, Room Essentials, Shade & Shore, Smartly, Smith & Hawken, Sonia Kashuk, Spritz, Sun Squad, Threshold, Universal Thread, up&up, Wild Fable, Wondershop, Xhilaration, California Roots, Casa Cantina, The Collection, Headliner, Jingle & Mingle, Rosé Bae, Photograph, SunPop, and Wine Cube. The company was founded by George Draper Dayton in 1902 and is headquartered in Minneapolis, MN.

Target Corp

Target is trending after reports revealed activist investor Toms Capital Investment Management acquired a significant stake, increasing pressure for strategic changes at the retailer. This has ignited community discussions and bullish options bets, with many highlighting Target's undervalued real estate and potential for a rebound despite its recent underperformance against sector leaders.

Madrigal Pharmaceuticals, Inc. engages in the development and commercialization of innovative therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product, MGL-3196, is used for the treatment of non-alcoholic steatohepatitis and familial hypercholesterolemia. The company was founded by Rebecca A. Taub, Frederick Bernard Craves, and Edward Chiang on March 10, 2000 and is headquartered in West Conshohocken, PA.

Madrigal Pharmaceuticals Inc

Madrigal Pharmaceuticals is surging due to robust Rezdiffra sales and recent positive F4 patient data, reinforcing its first-mover advantage in the burgeoning MASH market. This strong performance, alongside a European launch and numerous analyst price target upgrades, fuels widespread community speculation about a significant buyout. Investors are actively accumulating shares, anticipating substantial upside given the drug's foundational role and the heated MASH M&A landscape.

StoneCo Ltd. engages in the provision of financial technology solutions. It caters to merchants and partners that conduct electronic commerce across in-store, online, and mobile channels. The firm offers cloud-based technology platform, electronic payments, and automation of business processes at the point-of-sale. The company was founded by André Street de Aguiar in 2000 and is headquartered in George Town, Cayman Islands.

StoneCo Ltd - Ordinary Shares - Class A

StoneCo Ltd

StoneCo is trending following strong recent earnings beats, significant share buyback programs, and the strategic divestiture of its Linx software business to sharpen focus on the core MSMB segment. Community discussion highlights robust operational execution and impressive growth in areas like Pix adoption, alongside an attractive valuation. However, volatility and concerns about Brazil's political climate, including new fintech taxes, remain central to investor sentiment.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Smart Sand (NASDAQ:SND) Upgraded to "Strong-Buy" at Wall Street Zen

Wall Street Zen upgraded shares of Smart Sand from a "buy" rating to a "strong-buy" rating in a research report on Saturday...

Gendell Jeffrey L Has $4.10 Million Holdings in Smart Sand $SND

Gendell Jeffrey L boosted its holdings in Smart Sand (NASDAQ:SND - Free Report) by 18.1% in the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The...

Insider Buying: Smart Sand (NASDAQ:SND) Insider Buys 4,325 Shares of Stock

Smart Sand (NASDAQ:SND - Get Free Report) insider Ronald Whelan acquired 4,325 shares of the firm's stock in a transaction on Friday, November 28th. The shares were purchased at an average cost of...

Smart Sand to Issue Special Dividend of $0.05 (NASDAQ:SND)

Smart Sand (NASDAQ:SND) declared a special dividend on Tuesday, November 18th. Investors of record on Tuesday, December 2nd will be given a dividend of 0.05 per share on Tuesday, December 16th. The...

SMART SAND, INC. DECLARES SPECIAL DIVIDEND OF $0.05 PER SHARE

SMART SAND, INC. DECLARES SPECIAL DIVIDEND OF $0.05 PER SHARE SMART SAND, INC. DECLARES SPECIAL DIVIDEND OF $0.05 PER SHARE PR Newswire YARDLEY, Pa., Nov. 18, 2025 YARDLEY, Pa., Nov. 18, 2025...

Smart Sand (NASDAQ:SND) Trading Down 0.9% - Here's What Happened

Smart Sand (NASDAQ:SND) Stock Price Down 0.9% - Here's Why...

Smart Sand, Inc. Announces Third Quarter 2025 Results

Smart Sand, Inc. Announces Third Quarter 2025 Results Smart Sand, Inc. Announces Third Quarter 2025 Results PR Newswire YARDLEY, Pa., Nov. 12, 2025 3Q 2025 revenue of $92.8 million 3Q 2025 net income...

Smart Sand, Inc. engages in supplying frac sand and related services. The firm offers complete mine to wellsite proppant supply and logistics solutions. It operates through the Sand and SmartSystems segments. The Sand segment includes both frac sand sales and IPS sales. The SmartSystems segment focuses on the rental of patented SmartSystems equipment and related services provided to customers. The company was founded by Charles E. Young on July 19, 2011 and is headquartered in Yardley, PA.

Current Price	$3.86
Prev Close	$3.86
Open	$3.87
Dividend Yield	0.00%
50-Day Moving Average	$2.89
Beta	1.11
Avg. Volume	228,307.37
PE Ratio	39.47

52-Week High	$4.51
52-Week Low	$1.67
Market Capitalization	$174.71M
EPS (Annual)	$0.0766
Price to Book	0.63
Revenue Per Employee	$1.09M
Enterprise Value/EBITDA	N/A

SND
Smart Sand Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest SND News

SNDSmart Sand Inc